The global orthopedic cell therapy market was valued at $551.3 million in 2024 and is projected to grow at a CAGR of 7.2%, reaching $895.8 million by 2031.
This market includes two primary therapy types:
Platelet-Rich Cell Therapy
Bone Marrow Cell Therapy
Market Insights & Data Coverage
Unit Sales & Average Selling Prices
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data (2021-2023)
Competitive Landscape, Mergers & Acquisitions
Company Profiles & Product Portfolios
Market Trends
Impact of COVID-19 on Market Growth:
The COVID-19 pandemic caused a temporary decline in sales due to the postponement of elective procedures.
By 2022, the market rebounded, returning to a trajectory of steady growth.
Advancements in Cell Therapy Technology:
Growth in regenerative medicine is driving demand for platelet-rich plasma (PRP) and bone marrow aspirate (BMA) therapies.
Improved processing systems are enhancing the efficacy and adoption of orthopedic cell therapies.
Increased Adoption in Orthopedics & Sports Medicine:
Rising demand for minimally invasive treatments is fueling the market.
Soft tissue injuries, joint reconstructions, and spine treatments are key growth areas.
Market Share Insights
Top Competitors in the Global Orthopedic Cell Therapy Market (2024):
1 Terumo
Market leader with its Harvest Technologies division.
Offers Harvest® BMAC, Harvest® PRP, and the Harvest® AdiPrep® adipose tissue concentrator.
The Harvest® SmartPrep system enables multicellular processing for bone marrow, blood, and adipose tissue.
2 Zimmer Biomet
Second-largest market share with its Plasmax® Plasma concentration system and BioCUE™ System.
BioCUE™ System processes both bone marrow and whole blood for cell therapy applications.
3 Arthrex
Third-largest competitor, known for its Angel® cPRP and Bone Marrow Processing System.
The Angel® System automates the separation and concentration of PRP and BMA for orthopedic and soft tissue applications.
Market Segmentation Summary
Platelet-Rich Cell Therapy Market
Indications: Soft Tissue, Spine, Cardiac, Orthopedic, Plastics.
Bone Marrow Cell Therapy Market
Indications: Soft Tissue, Spine, Trauma, Joint Reconstructions.
Global Research Scope
Regions Covered:
North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
Western Europe (Germany, France, U.K., Spain, Italy)
Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
Middle East (Saudi Arabia, UAE, Israel)
Asia Pacific (China, Japan, India, South Korea, Australia)
Africa (South Africa, Egypt, Nigeria, Kenya)
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage
Market Size, Market Shares
Market Forecasts, Growth Rates
Units Sold, Average Selling Prices
Procedure Numbers
Qualitative Coverage
COVID-19 Impact
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls, Disruptive Technologies
Disease Overviews
Data Sources:
Primary Interviews with Industry Leaders
Government Physician Data & Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
- 6.1 EXECUTIVE SUMMARY <
- 6.1.1 Global Orthopedic Cell Therapy Market Overview
- 6.1.2 Competitive Analysis
- 6.1.3 Procedure Segmentation
- 6.1.4 Market Segmentation
- 6.1.5 Regions Included
- 6.2 INTRODUCTION
- 6.2.1 Platelet-Rich Plasma
- 6.2.2 Concentrated Bone Marrow Aspirate
- 6.3 PROCEDURE NUMBERS
- 6.3.1 Total Orthopedic Cell Therapy Procedures
- 6.3.2 Platelet-Rich Plasma Procedures
- 6.3.3 Bone Marrow Aspirate Concentrate Procedures
- 6.4 MARKET OVERVIEW
- 6.4.1 By Segment
- 6.4.2 By Region
- 6.5 MARKET ANALYSIS AND FORECAST
- 6.5.1 Platelet-Rich Plasma Market
- 6.5.2 Bone Marrow Aspirate Concentrate Market
- 6.6 UNIT ANALYSIS
- 6.6.1 Platelet-Rich Plasma Unit Analysis
- 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
- 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
- 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
- 6.7 DRIVERS AND LIMITERS
- 6.7.1 Market Drivers
- 6.7.2 Market Limiters
- 6.8 COMPETITIVE MARKET SHARE ANALYSIS
- Chart 6 1: Orthopedic Cell Therapy Market, Global, 2024 & 2031
- Chart 6 2: Orthopedic Cell Therapy Procedures, Global, 2024
- Chart 6 3: Orthopedic Cell Therapy Procedures by Region, Global, 2021 – 2031
- Chart 6 4: Orthopedic Cell Therapy Market by Segment, Global, 2021 – 2031
- Chart 6 5: Orthopedic Cell Therapy Market by Region, Global, 2021 – 2031
- Chart 6 6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024
- Figure 6 1: Orthopedic Cell Therapy Procedure Segmentation
- Figure 6 2: Orthopedic Cell Therapy Market Segmentation
- Figure 6 3: Orthopedic Cell Therapy Regions Covered, Global (1 of 2)
- Figure 6 4: Orthopedic Cell Therapy Regions Covered, Global (2 of 2)
- Figure 6 5: Orthopedic Cell Therapy Procedures by Segment, Global, 2021 – 2031
- Figure 6 6: Orthopedic Cell Therapy Procedures by Region, Global, 2021 – 2031
- Figure 6 7: Orthopedic Cell Therapy Procedures by Country, North America, 2021– 2031
- Figure 6 8: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 6 9: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 6 10: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2021 – 2031
- Figure 6 11: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 6 12: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 6 13: Orthopedic Cell Therapy Procedures by Country, Middle East, 2021 – 2031
- Figure 6 14: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 6 15: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 6 16: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 6 17: Orthopedic Cell Therapy Procedures by Country, Africa, 2021 – 2031
- Figure 6 18: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2021 – 2031
- Figure 6 19: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2021 – 2031
- Figure 6 20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 6 21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 6 22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2021 – 2031
- Figure 6 23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 6 24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 6 25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2021 – 2031
- Figure 6 26: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 6 27: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 6 28: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 6 29: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2021 – 2031
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook